Effect of injection iron in improving haemoglobin level among pregnant wome
Phase 4
- Conditions
- Health Condition 1: null- Moderate to Severe Anaemia
- Registration Number
- CTRI/2017/09/009720
- Lead Sponsor
- All India Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 75
Inclusion Criteria
1.Pregnant women in 16-32 weeks with anemia (Hb levels 5.0- 9.9 g/dl)
2.Those who give written consent and agree to cooperate for all measurements at different time points
Exclusion Criteria
1.Those having renal or hepatic impairment
2.Women having Hb <5gm%
3.Women having previous history of parenteral iron administration
4.Allergy to iron preparations
5.Known case of thalassemia, sickle cell anaemia or haemolytic anaemia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean increase in Hb levels at 2 weeks after administration of FCM.Timepoint: Mean increase in Hb levels at 2 weeks after administration of FCM.
- Secondary Outcome Measures
Name Time Method Adverse events after administration of FCM.Timepoint: at the time of administration, 2 weeks, delivery and 6 months postpartum;Mean increase in Hb levels at delivery and 6 months postpartum.Timepoint: Delivery and 6 months postpartum;Mean increase in Serum Ferritin level at 6 months postpartum.Timepoint: 6 months postpartum;Oxidative stress markers after administration of FCM.Timepoint: 2 weeks, delivery and 6 months post partum